The LJMC has won many awards for its innovative approach to helping people affected by cancer:

  • Awarded the Macmillan Quality Environment Mark (2015).
  • Team Excellence Award at the annual Macmillan Professionals Awards 2013.
  • Novartis Cancer Charity Initiative of the Year 2012 (part of the Quality in Care Oncology awards): Shortlisted for the work to improve patients’ experience prior to starting chemotherapy.
  • Information Standard: Achieved certification to the Information Standard in January 2011. This scheme closed in 2019 but the Information team continues to follow the criteria laid down in the IS in order to produce the best quality information publications that meet the needs and expectations of our service users.
  • Beacon Status (2010): Supporting healthcare professionals in the implementation of the NHS Choices Information Prescription Service, an online tool to provide good quality information to patients at all stages of their cancer journey. Developing new ways of bringing information to patients.
  • TNT Partnership Awards (2002): Finalists in the competition for organisations which develop and sustain effective partnerships.
  • Beacon Award (1999-2001): An NHS initiative to boost the spread of good practice in service delivery and management.
  • NHS Nye Bevan Award (1999): for outstanding contribution to excellence and innovation in the treatment and care of patients.
  • Prime Minister’s Commendation (1999) for demonstrating the most innovative ways of spreading best practice and information about our pioneering work within the NHS.
  • Foundation for Integrated Medicine (1999 and 2001): Awards for Good Practice in Integrated Healthcare: finalists.

The LJMC has also been commended for its work in a number of publications:

  • “Specific areas of noted best practice were the Lynda Jackson Macmillan Centre where good practice is integrated into the service and supports both patients and staff.”
    East and North Hertfordshire Clinical Commissioning Group (2014)
  • “An area of existing good practice from which the rest of the Trust could learn more.”
    Commission for Health Improvement review of West Hertfordshire Hospitals NHS Trust (2002)
  • “The model of good practice for supportive information.”
    The Cancer Plan (2000)

British Medical Association Patient Information Awards

BMA Patient Information Awards

A number of LJMC publications have received commendations in the BMA’s annual Patient Information Awards. These awards aim to support and encourage patient-centred care through the production and dissemination of accessible, well-designed and clinically balanced information.

  • PEG tubes
  • Neutropenia
  • Radiotherapy for Hodgkin lymphoma
  • Resuscitation
  • Radical hysterectomy (HC)
  • Prostate brachytherapy using permanent implants
  • Ear acupuncture
  • Radiotherapy for brain tumours (HC)
  • Gastrectomy (HC)
  • Cryotherapy for the treatment of prostate cancer (HC)
  • Chemoradiation for an oesophageal cancer
  • Oesophagectomy
  • Radiotherapy to the breast
  • CyberKnife treatment for lung cancer (HC)
  • CyberKnife treatment to the brain
  • CyberKnife treatment for pancreatic cancer
  • CyberKnife treatment for prostate cancer
  • Now that you have started your chemotherapy (HC)
  • Radiotherapy to the head, neck, mouth and throat (HC)
  • Chemoradiotherapy to the head, neck, mouth and throat
    (Winner: Information produced by NHS Trusts Award)
  • Cetuximab and radiotherapy to the head, neck, mouth and throat (HC)
  • Radical chemoradiotherapy/radiotherapy for lung cancer (HC)
  • Coping, now your chemotherapy is finishing (HC)
  • Head & neck aftercare service (HC)
  • Using moxa to reduce the side effects of chemotherapy (HC)
  • Relaxation and breathing techniques
    (Runner-up: Information produced by NHS Trusts Award)

(HC=Highly Commended)